Market Scenario
Moebius syndrome is a rare neurological condition characterized by paralysis of multiple cranial nerves, and most often the abducens and facial nerves. Signs and symptoms of Moebius include paralysis of the facial muscles, swallowing and choking problems, crossed eyes, bone abnormalities in the hands, speech difficulties, high or cleft palate, excessive drooling, and various others. As per the National Center for Advancing Translational Sciences, abnormality of the voice, masklike facies, Bell's palsy, feeding difficulties in infancy, and open mouth commonly occur in 80%-99% cases of Moebius syndrome.
Browse Sample of the Report @ https://www.marketresearchfuture.com/sample_request/5407
According to the U.S National Library of Medicine, Moebius syndrome affects 1 in 50,000 to 1 in 500,000 newborns. It also mentions that the affected individuals lack facial expressions i.e. they cannot smile, or raise their eyebrows.
It is noted that growing public awareness and technological advancements are the key factors driving the Moebius syndrome treatment market. On the technology front, various surgical options have been used for an effective management of symptoms associated with Moebius syndrome such as facial nerve grafting, facial nerve decompression, transposition of the temporalis muscle, and others.
Various other factors such as unmet medical needs, increasing government assistance, rising healthcare expenditure in the developed countries, improving regulatory framework, increasing adoption rate, and rising funding and reimbursement policies are continuously contributing to the growth of the global Moebius syndrome market. According to the Centers for Disease Control and Prevention in 2015, the total health expenditure in the United States was reported to be USD 3.2 trillion and the hospital care accounted for a share of 32.3%.
Despite these drivers, there are some issues associated with Moebius syndrome market. The complications associated with the available treatments, infections, and injuries caused by surgical devices, and poor healthcare system in low and middle-income countries, may hinder the growth of the market.
It is estimated that the Moebius syndrome market is expected to grow at a CAGR of 6.5% during the forecast period of 2017-2023.
Key Players
Some of key the players in the global moebius syndrome market are Alcon Laboratories, Inc, All Vascular, Pty Ltd., Aspen Surgical Products, Inc., B. Braun Melsungen AG, Becton, Dickinson and Company, Boston Scientific Corporation, Conmed Corporation, Gray Surgical, Johnson & Johnson Services, Inc., Medtronic, Olympus Corporation, Smith & Nephew plc, TransEnterix Surgical, Inc., Zimmer Biomet Holdings, Inc., and others.
FOR MORE DETAILS – https://www.marketresearchfuture.com/reports/moebius-syndrome-market-5407
No comments:
Post a Comment